Streamline Non Current Assets Total vs Non Current Liabilities Total Analysis
STRM Stock | USD 0.33 0.04 13.79% |
Streamline Health financial indicator trend analysis is much more than just breaking down Streamline Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Streamline Health is a good investment. Please check the relationship between Streamline Health Non Current Assets Total and its Non Current Liabilities Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Non Current Assets Total vs Non Current Liabilities Total
Non Current Assets Total vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Streamline Health Non Current Assets Total account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Streamline Health's Non Current Assets Total and Non Current Liabilities Total is 0.73. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Streamline Health Solutions, assuming nothing else is changed. The correlation between historical values of Streamline Health's Non Current Assets Total and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Streamline Health Solutions are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Non Current Assets Total i.e., Streamline Health's Non Current Assets Total and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Non Current Liabilities Total
Most indicators from Streamline Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Streamline Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Streamline Health's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 8th of May 2024, Enterprise Value is likely to grow to about 32.2 M, while Selling General Administrative is likely to drop about 8.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 17.4M | 24.9M | 22.6M | 19.1M | Depreciation And Amortization | 5.1M | 4.5M | 4.9M | 2.9M |
Streamline Health fundamental ratios Correlations
Click cells to compare fundamentals
Streamline Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Streamline Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Short Long Term Debt Total | 3.8M | 2.7M | 10.1M | 9.7M | 10.6M | 6.0M | |
Other Current Liab | 2.5M | 1.5M | 6.5M | 7.0M | 3.8M | 2.8M | |
Total Current Liabilities | 15.6M | 7.4M | 13.5M | 16.8M | 13.7M | 10.2M | |
Total Stockholder Equity | 16.0M | 17.5M | 34.0M | 35.5M | 18.8M | 15.7M | |
Property Plant And Equipment Net | 152K | 495K | 341K | 111K | 88K | 83.6K | |
Net Debt | 2.2M | 312K | 256K | 3.2M | 7.4M | 7.7M | |
Retained Earnings | (79.4M) | (79.1M) | (85.7M) | (97.0M) | (115.7M) | (109.9M) | |
Accounts Payable | 1.3M | 272K | 778K | 626K | 1.3M | 1.1M | |
Non Current Assets Total | 25.1M | 18.7M | 46.7M | 45.5M | 32.9M | 19.4M | |
Non Currrent Assets Other | 695K | 886K | 948K | 1.7M | 1.7M | 1.2M | |
Net Receivables | 4.0M | 3.1M | 4.7M | 8.7M | 5.0M | 5.1M | |
Common Stock Shares Outstanding | 22.7M | 30.2M | 42.8M | 49.3M | 56.5M | 59.3M | |
Liabilities And Stockholders Equity | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Non Current Liabilities Total | 55K | 1.1M | 14.3M | 9.2M | 9.2M | 6.8M | |
Other Current Assets | 919K | 416K | 568K | 710K | 629K | 1.2M | |
Other Stockholder Equity | 95.1M | 96.3M | 119.2M | 132.0M | 133.9M | 140.6M | |
Total Liab | 15.6M | 8.5M | 27.8M | 26.0M | 22.9M | 16.6M | |
Total Current Assets | 6.6M | 7.3M | 15.1M | 16.0M | 8.8M | 12.7M | |
Short Term Debt | 3.8M | 1.7M | 454K | 785K | 1.5M | 1.2M | |
Cash | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Cash And Short Term Investments | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Property Plant And Equipment Gross | 152K | 495K | 341K | 357K | 379K | 360.1K | |
Other Liab | 55K | 130K | 4.6M | 271K | 311.7K | 296.1K | |
Other Assets | 695K | 886K | 948K | 1.7M | 1.5M | 1.0M | |
Common Stock Total Equity | 208K | 305K | 316K | 576K | 662.4K | 695.5K | |
Common Stock | 305K | 316K | 478K | 576K | 590K | 619.5K | |
Property Plant Equipment | 152K | 104K | 341K | 5.9M | 6.8M | 7.2M | |
Current Deferred Revenue | 8.0M | 3.9M | 5.8M | 8.4M | 7.1M | 6.8M | |
Intangible Assets | 8.7M | 6.6M | 22.3M | 20.6M | 17.9M | 13.0M | |
Inventory | 1.3M | 901K | 1.4M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | (8.2M) | 208K | (11.4M) | (2.4M) | (2.7M) | (2.9M) | |
Retained Earnings Total Equity | (76.6M) | (79.4M) | (79.1M) | (97.0M) | (87.3M) | (91.7M) | |
Long Term Debt Total | 3.9M | 3.4M | 989K | 9.0M | 8.1M | 5.4M | |
Capital Surpluse | 82.5M | 95.1M | 96.3M | 132.0M | 151.8M | 89.1M | |
Deferred Long Term Liab | 55K | 130K | 806K | 167K | 150.3K | 142.8K |
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.33) | Revenue Per Share 0.4 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.